Provides limitations on overlapping control between insurance companies and pharmacy benefits managers and pharmacies; requires divestment of the interest in one or more insurance companies and pharmacy benefits managers.
- Chamber
- Senate
- Introduced
- Feb 12, 2026
- Last action
- Feb 12, 2026 — REFERRED TO JUDICIARY
- Session
- 2025-2026
- Momentum
- 26 · Low